TP53 and hepatocellular carcinoma: This finding is consistent with the observation that TP53 mutation and TP53-deficient HCC cells bypass senescence and secrete factors that stimulate macrophages into a tumor-promoting M2 state, promoting pro-tumor immune infiltrate62,63.